WHERE IS GSK LISTED?

The Pharmaceutical Giant's Stock Market Presence

GlaxoSmithKline (GSK) is a British multinational pharmaceutical, biopharmaceutical, and consumer healthcare company headquartered in Brentford, London. It is one of the world's largest pharmaceutical companies and has a rich history dating back to the 18th century. GSK's products are sold in over 150 countries, and it employs approximately 100,000 people worldwide.

GSK's Stock Market Listings

As a publicly traded company, GSK's shares are listed on several stock exchanges around the world. Its primary listing is on the London Stock Exchange (LSE), where it is a constituent of the FTSE 100 Index. GSK is also listed on the New York Stock Exchange (NYSE) and the Hong Kong Stock Exchange (HKEX).

London Stock Exchange (LSE)

The London Stock Exchange is one of the world's oldest and most prestigious stock exchanges. It was founded in 1801 and is home to over 2,000 listed companies. GSK has been listed on the LSE since 1989 and is one of the largest companies on the exchange by market capitalization.

New York Stock Exchange (NYSE)

The New York Stock Exchange is the largest stock exchange in the world by market capitalization. It was founded in 1792 and is home to over 2,000 listed companies. GSK has been listed on the NYSE since 1993 and is one of the largest foreign companies on the exchange.

Hong Kong Stock Exchange (HKEX)

The Hong Kong Stock Exchange is the fourth largest stock exchange in Asia by market capitalization. It was founded in 1891 and is home to over 2,000 listed companies. GSK has been listed on the HKEX since 1994 and is one of the largest foreign companies on the exchange.

Benefits of Being Listed on Multiple Stock Exchanges

There are several benefits to being listed on multiple stock exchanges. These include:

• Increased liquidity: Listing on multiple exchanges increases the number of potential buyers and sellers of a company's shares, which can lead to increased liquidity.
• Access to a wider investor base: Listing on multiple exchanges gives a company access to a wider pool of investors, both domestic and international.
• Enhanced reputation: Being listed on multiple exchanges can enhance a company's reputation and make it more attractive to investors.
• Reduced risk: Listing on multiple exchanges can help to reduce a company's risk by diversifying its investor base.

Conclusion

GSK is a global pharmaceutical giant with a presence in over 150 countries. Its shares are listed on several stock exchanges around the world, including the London Stock Exchange, the New York Stock Exchange, and the Hong Kong Stock Exchange. Being listed on multiple exchanges provides GSK with several benefits, including increased liquidity, access to a wider investor base, an enhanced reputation, and reduced risk.

Frequently Asked Questions

• What is GSK's primary stock market listing?

GSK's primary stock market listing is on the London Stock Exchange (LSE).

• When did GSK first list on the LSE?

GSK first listed on the LSE in 1989.

• What other stock exchanges is GSK listed on?

GSK is also listed on the New York Stock Exchange (NYSE) and the Hong Kong Stock Exchange (HKEX).

• What are the benefits of being listed on multiple stock exchanges?

The benefits of being listed on multiple stock exchanges include increased liquidity, access to a wider investor base, an enhanced reputation, and reduced risk.

• What is GSK's market capitalization?

GSK's market capitalization is approximately £80 billion (as of July 2023).